DLGAP1 and breast carcinoma: In breast cancer (BRC), WTAP binds to the m6A site of DLGAP1-AS1 and promotes its stability, while lncRNA DLGAP1-AS1 in turn increases its adriamycin resistance through the WTAP/DLGAP1-AS1/miR-299-3p feedback loop (Huang et al., 2021).